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Patients with grown-up congenital heart (GUCH) disease pose a few unique problems for the 
cardiac electrophysiologist due to the myocardial substrate with high propensity for arrhythmias. 
Arrhythmias are the main reason for hospital admission in these patients and, unfortunately, in a 
significant proportion of these patients, these arrhythmic events could be life-threatening [1]. 
Furthermore, the onset of arrhythmias may herald the hemodynamic decompensation in a 
sizable segment of the population with already compromised functional status. The abnormal 
circulation, in turn, may amplify the hemodynamic effect of arrhythmias in these patients with 
unrepaired or partially repaired abnormal cardiac anatomy.                                            
Previous studies into the natural history of patients with GUCH have been helpful in identifying 
the likely risk factors for arrhythmogenesis, and the associated risk of sudden cardiac death 
(SCD) in them [2-4]. Clinical variables like older age at repair, ventricular dysfunction, and 
need of ventriculotomy at repair are known to adversely affect the survival in patients with 
GUCH [2-4]. In majority, the increased arrhythmogenecity, at cellular level, is mediated by the 
co-existing myocardial fibrosis. Ventricular fibrosis suggested by cardiovascular magnetic 
resonance is known to be an important marker of poor survival in adults with repaired tetralogy 
of Fallot (TOF) [5]. Additional evidence for myocardial fibrosis in these patients is that re-
entrant mechanisms, as often seen with scarring, account for majority of their arrhythmias. 
As myocardial scarring can be taken as a surrogate marker of arrhythmogenesis in these 
patients, it is important to recognise the factors contributing to its development in them. The 
patients who had undergone ventriculotomy and / or patching for ventricular septal defects, who 
carry the highest risk of developing ventricular arrhythmias in GUCH, have a well-defined 
surgical scar. As described earlier for intraatrial-reentrant tachyarrhythmias associated with 
atriotomy scars, the macro-reentrant circuits in post-ventriculotomy patients tend to use narrow 
isthmuses within the surgical scars or between the scars and anatomical barriers like valves or 
patches for its perpetuation [6]. In either of the above mechanisms, the surgical scars tend to 
determine the circuits and thereby, the targets of ablation. Zeppenfeld et al had demonstrated 
that the placement of a single ventriculotomy, outflow tract patch, or transannular patch, along 
with closure of the ventricular septal defect, would be expected to create only a limited number 
of possible tachycardia circuits [7]. However, diffuse or localised myocardial fibrosis- the 
second substrate apart from scar - can also contribute to arrhythmogenesis in a significant 
proportion of patients with GUCH. The abnormal hypertrophic response, chamber dilatation, 
myocardial disarray etc. could account for these additional factors in these patients with high 
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likelihood of developing pressure and/or volume overload of cardiac chambers. Myocardial 
scarring secondary to hemodynamic factors have already been described in patients with GUCH 
with   various   underlying   cardiac   anomalies   [8].   These   include   patients   with   corrected 
transposition, Ebstein's anomaly, single ventricle, Eissenmenger's syndrome and unrepaired 
TOF.
In this issue of the journal, Selvaraj et al describe a case where the circuit of the ventricular 
tachycardia was mapped to a site far away from scar in a patient who had undergone 
ventriculotomy as a part of surgical correction of double-chambered right ventricle [9]. 
Myocardial fibrosis, as defined by the voltage map settings, showed scar at right ventricular 
apex in this case. Due to the hemodynamic instability associated with the tachycardia, the 
authors could not perform detailed entrainment mapping techniques to delineate the circuits, and 
had to ablate based on pace mapping. Despite these limitations, the response to ablation at right 
ventricular apex was validated by the clinical response with no recurrence on follow up.  The 
authors hypothesise the prolonged exposure of right ventricular apex to high pressures could 
account for the localised scarring noted in this case. This proposed association between this 
regional myocardial scarring unrelated to the prior ventriculotomy and the potential targets of 
successful ablation is important in an era where the hunt for the optimal targets of ablation in 
complex arrhythmias is continuing. This is more  relevant  in patients with GUCH  and 
arrhythmia, where alternative therapeutic options are limited. The negative inotropic effects and 
safety concerns of antiarrhythmic drugs limit their wide usage, especially at high doses often 
required  to prevent recurrence  of arrhythmias in them. The indications for  implantable 
defibrillators are also not well established. Due to these concerns, though the results of catheter-
based ablation are far from satisfactory, electrophysiological testing and/or ablation are 
considered  as a worthy option for symptomatic patients with suspected or documented 
ventricular arrhythmia. Identification of these additional mechanisms of arrhythmogenesis and 
possible targets of ablation carries greater significance in this scenario.                      
The therapeutic algorithms for the management of arrhythmias tend to differ in these patients 
owing to the heterogeneity of the anatomical and physiological substrate. Despite this limitation, 
this report underscores an important fact that the arrhythmogenic substrate in congenital heart 
disease may not necessarily be the ventriculotomy scar alone, and the second substrate -the 
fibrosis related to the myocardial remodelling due to chamber hypertrophy or dilatation - could 
be contributory in many. Duration of exposure of heart to the abnormal hemodynamic burden 
may be the most important factor determining the degree of remodelling and, thereby, fibrosis. 
The higher risk of SCD in TOF patients repaired after 20 years of age have already been 
described [3]. In a large, multicenter study, nearly 100% of patients with TOF who had their 
surgical procedure performed after 10 years of age had ventricular arrhythmias [10]. Similarly, 
electrical remodelling in atria is known to occur by adolescence in patients with atrial septal 
defects, and this has been found as a major risk factor for atrial arrhythmias in postoperative 
patients with delayed age at repair [11]. These facts clearly point towards the complementary 
role of myocardial fibrosis as an additional arrhythmogenic factor apart from surgical scar in 
these patients. However, more studies are required to identify the mechanisms of complex 
electrophysiological interaction between the scar and this 'second substrate' in initiation and 
perpetuation   of   these   re-entrant   arrhythmias   in   patients   with   congenital   heart   disease.
References
1. Somerville J. Management of adults with congenital heart disease: an increasing problem. 
Annu   Rev   Med   1997;   48:   283–93.                                                              
2. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is 
a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll 
Cardiol   2002;40:   1675–80.                                                                                
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (1): 1-3 (2012)Namboodiri N, “Ablation of Ventricular Arrhythmias in GUCH”                                            3
3. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa 
M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden 
cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975–
81.
4. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic 
significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective 
study. J Am Coll Cardiol 1994; 23: 1151–5.                                                                 
5. Babu-Narayan SV, Kilner PJ, LiW, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, 
Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic resonance 
in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical 
outcome. Circulation 2006; 113: 405–13.                                                                       
6. Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, Spector P, 
Calame JD, Rao A, Hasdemir C, Otomo K, Wang Z, Lazzara R, Jackman WM. Characterization 
of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital 
heart disease: isolated channels between scars allow “focal” ablation. Circulation. 2001; 103: 
699   –709.                                                                                                      
7. Zeppenfeld K, Schalij MJ, Bartelings MM, Tedrow UB, Koplan BA, Soejima K, Stevenson 
WG. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: 
electroanatomic   identification   of   the   critical   right   ventricular   isthmus.   Circulation. 
2007;116:2241–2252.
8. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with 
congenital heart disease. Am J Cardiol 2000;86:1111–16.                                              
9. Selvaraj RJ, Gobu p, Ashida TS, George G, Balachander J. Ventricular tachycardia in 
repaired double chambered right ventricle - identification of the substrate and successful 
ablation. Indian Pacing Electrophysiol. J. 2012;12:24-26.                                                         
10. Chandar JS, Wolff S, Garson A Jr, Bell TJ, Beder SD, Bink-Boelkens M, Byrum CJ, 
Campbell RM, Deal BJ, Dick M, et al. Ventricular arrhythmias in postoperative tetralogy of 
Fallot. Am J Cardiol 1990; 65: 655–661.                                                                               
11. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for 
secundum atrial septal defects in patients > 40 years old. A randomized clinical trial. J Am Coll 
Cardiol 2001; 38: 2035–42.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (1): 1-3 (2012)